Reply to E. C. Smyth et al

J Clin Oncol. 2014 Sep 20;32(27):3081-2. doi: 10.1200/JCO.2014.56.3866. Epub 2014 Jul 28.

Authors

Maarten C C M Hulshof¹, Vera Oppedijk², Ate van der Gaast³

Affiliations

¹ Academic Medical Center of Amsterdam, Amsterdam, the Netherlands m.c.hulshof@amc.uva.nl.
² Academic Medical Center of Amsterdam, Amsterdam, the Netherlands.
³ Erasmus Medical Center, Rotterdam, the Netherlands.

PMID: 25071131
DOI: 10.1200/JCO.2014.56.3866

No abstract available

Publication types

Letter
Comment

MeSH terms

Adenocarcinoma / therapy*
Carcinoma, Squamous Cell / therapy*
Chemotherapy, Adjuvant*
Esophageal Neoplasms / therapy*
Esophagectomy*
Esophagogastric Junction*
Female
Gastrectomy / adverse effects*
Humans
Male
Neoadjuvant Therapy*
Neoplasm Recurrence, Local / prevention & control*
Stomach Neoplasms / therapy*